We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
AUM
$92.9M
AUM Growth
+$2.37M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENTL
1
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$49M 52.7%
2,956,456
KALV
2
DELISTED
KalVista Pharmaceuticals
KALV
$19M 20.43%
2,579,490
OCUL icon
3
Ocular Therapeutix
OCUL
$2.38B
$14.9M 16.02%
1,605,207
ASXC
4
DELISTED
Asensus Surgical, Inc.
ASXC
$5.36M 5.77%
580,515
ATXS
5
DELISTED
Astria Therapeutics
ATXS
$4.03M 4.34%
47,628
EVAR
6
DELISTED
Lombard Medical, Inc.
EVAR
$701K 0.75%
1,275,779

Similar funds

SV Health Investors's Q2 2017 Portfolio in Review

As of Q2 2017, SV Health Investors held 6 positions worth $92.9M, up 2.6% from $90.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 0%. SV Health Investors opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • SV Health Investors's ten largest holdings make up 100% of its $92.9M portfolio in Q2 2017.
  • SV Health Investors opened 0 new positions and closed 0 in Q2 2017.
  • SV Health Investors's portfolio value rose 2.6% quarter-over-quarter to $92.9M.

Based on SV Health Investors's 13F filing for Q2 2017, filed 10 Aug 2017.